PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Global medical foot insoles market by polypropylene insoles • Global medical foot insoles market by leather insoles • Global medical foot insoles market by other insoles • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Medical foot insoles market in Americas • Medical foot insoles market in EMEA • Medical foot insoles market in APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Rise in use of eco-friendly medical insoles • Demand for custom and premium products • High potential in developing countries PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bauerfeind • Bayer Group • Implus • Powerstep • SOLO Laboratories • Superfeet Worldwide PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market: Global foot insoles market Exhibit 02: Global foot insoles market Exhibit 03: Market characteristics Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global medical foot insoles market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global medical foot insoles market – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017and 2022 Exhibit 18: Global medical foot insoles market by product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global medical foot insoles market by polypropylene insoles – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global medical foot insoles market by polypropylene insoles – Year over year growth 2018-2022 (%) Exhibit 22: Global medical foot insoles market by leather insoles – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global medical foot insoles market by leather insoles – Year over year growth 2018-2022 (%) Exhibit 24: Global medical foot insoles market by other insoles – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Global medical foot insoles market by other insoles – Year over year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global medical foot insoles market by region – Market share 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Medical foot insoles market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Medical foot insoles market in Americas – Year over year growth 2018-2022 (%) Exhibit 32: Top three countries in Americas Exhibit 33: Medical foot insoles market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: Medical foot insoles market in EMEA – Year over year growth 2018-2022 (%) Exhibit 35: Top three countries in EMEA Exhibit 36: Medical foot insoles market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: Medical foot insoles market in APAC – Year over year growth 2018-2022 (%) Exhibit 38: Top three countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Bauerfeind overview Exhibit 46: Bauerfeind – Business segments Exhibit 47: Bauerfeind – Organizational developments Exhibit 48: Bauerfeind – Geographic focus Exhibit 49: Bauerfeind – Segment focus Exhibit 50: Bauerfeind – Key offerings Exhibit 51: Bayer Group overview Exhibit 52: Bayer Group – Business segments Exhibit 53: Bayer Group – Organizational developments Exhibit 54: Bayer Group – Geographic focus Exhibit 55: Bayer Group – Segment focus Exhibit 56: Bayer Group – Key offerings Exhibit 57: Implus overview Exhibit 58: Implus – Business segments Exhibit 59: Implus – Organizational developments Exhibit 60: Implus – Geographic focus Exhibit 61: Implus – Segment focus Exhibit 62: Implus – Key offerings Exhibit 63: Powerstep overview Exhibit 64: Powerstep – Business segments Exhibit 65: Powerstep – Organizational developments Exhibit 66: Powerstep – Geographic focus Exhibit 67: Powerstep – Segment focus Exhibit 68: Powerstep – Key offerings Exhibit 69: SOLO Laboratories overview Exhibit 70: SOLO Laboratories – Business segments Exhibit 71: SOLO Laboratories – Organizational developments Exhibit 72: SOLO Laboratories – Geographic focus Exhibit 73: SOLO Laboratories – Segment focus Exhibit 74: SOLO Laboratories – Key offerings Exhibit 75: Superfeet Worldwide overview Exhibit 76: Superfeet Worldwide – Business segments Exhibit 77: Superfeet Worldwide – Organizational developments Exhibit 78: Superfeet Worldwide – Geographic focus Exhibit 79: Superfeet Worldwide – Segment focus Exhibit 80: Superfeet Worldwide – Key offerings

Bauerfeind Bayer Group Implus Powerstep SOLO Laboratories Superfeet Worldwide